BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 37540187)

  • 1. Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma.
    Li B; Li Y; Zhou H; Xu Y; Cao Y; Cheng C; Peng J; Li H; Zhang L; Su K; Xu Z; Hu Y; Lu J; Lu Y; Qian L; Wang Y; Zhang Y; Liu Q; Xie Y; Guo S; Mehal WZ; Yu D
    Hepatology; 2024 Feb; 79(2):289-306. PubMed ID: 37540187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology.
    Ji S; Feng L; Fu Z; Wu G; Wu Y; Lin Y; Lu D; Song Y; Cui P; Yang Z; Sang C; Song G; Cai S; Li Y; Lin H; Zhang S; Wang X; Qiu S; Zhang X; Hua G; Li J; Zhou J; Dai Z; Wang X; Ding L; Wang P; Gao D; Zhang B; Rodriguez H; Fan J; Clevers H; Zhou H; Sun Y; Gao Q
    Sci Transl Med; 2023 Jul; 15(706):eadg3358. PubMed ID: 37494474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illuminating the immunological landscape: mitochondrial gene defects in pancreatic cancer through a multiomics lens.
    Chi H; Su L; Yan Y; Gu X; Su K; Li H; Yu L; Liu J; Wang J; Wu Q; Yang G
    Front Immunol; 2024; 15():1375143. PubMed ID: 38510247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiomics: paving the path towards personalized prevention of hypertension.
    Latosinska A; Siwy J; Mischak H
    J Hypertens; 2024 Jun; 42(6):962-964. PubMed ID: 38690900
    [No Abstract]   [Full Text] [Related]  

  • 5. Rare tumor subtypes diagnosed by molecular analysis.
    Matsumura N
    Int Cancer Conf J; 2021 Apr; 10(2):95. PubMed ID: 33786283
    [No Abstract]   [Full Text] [Related]  

  • 6. From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification.
    Fan Z; Jin M; Zhang L; Wang N; Li M; Wang C; Wei F; Zhang P; Du X; Sun X; Qiu W; Wang M; Wang H; Shi X; Ye J; Jiang C; Zhou J; Chai W; Qi J; Li T; Zhang R; Liu X; Huang B; Chai K; Cao Y; Mu W; Huang Y; Yang T; Zhang H; Qu L; Liu Y; Wang G; Lv G
    Gut; 2023 Nov; 72(11):2149-2163. PubMed ID: 37549980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance.
    Jiang S; Deng T; Cheng H; Liu W; Shi D; Yuan J; He Z; Wang W; Chen B; Ma L; Zhang X; Gong P
    J Exp Clin Cancer Res; 2023 Aug; 42(1):199. PubMed ID: 37553567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis and immune landscape of chemokines- and chemokine receptors-based signature in hepatocellular carcinoma.
    Zhang Z; Mao M; Wang F; Zhang Y; Shi J; Chang L; Wu X; Zhang Z; Xu P; Lu S
    Front Immunol; 2023; 14():1164669. PubMed ID: 37545521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer.
    Cai Y; Cheng Y; Wang Z; Li L; Qian Z; Xia W; Yu W
    BMC Cancer; 2023 Aug; 23(1):725. PubMed ID: 37543645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes.
    Wang G; Li J; Zhu L; Zhou Z; Ma Z; Zhang H; Yang Y; Niu Q; Wang X
    Discov Oncol; 2023 Aug; 14(1):147. PubMed ID: 37555866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Friend or foe? The elusive role of hepatic stellate cells in liver cancer.
    Cogliati B; Yashaswini CN; Wang S; Sia D; Friedman SL
    Nat Rev Gastroenterol Hepatol; 2023 Oct; 20(10):647-661. PubMed ID: 37550577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer.
    Chowdhury S; Kennedy JJ; Ivey RG; Murillo OD; Hosseini N; Song X; Petralia F; Calinawan A; Savage SR; Berry AB; Reva B; Ozbek U; Krek A; Ma W; da Veiga Leprevost F; Ji J; Yoo S; Lin C; Voytovich UJ; Huang Y; Lee SH; Bergan L; Lorentzen TD; Mesri M; Rodriguez H; Hoofnagle AN; Herbert ZT; Nesvizhskii AI; Zhang B; Whiteaker JR; Fenyo D; McKerrow W; Wang J; Schürer SC; Stathias V; Chen XS; Barcellos-Hoff MH; Starr TK; Winterhoff BJ; Nelson AC; Mok SC; Kaufmann SH; Drescher C; Cieslik M; Wang P; Birrer MJ; Paulovich AG
    Cell; 2023 Aug; 186(16):3476-3498.e35. PubMed ID: 37541199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stress.
    Huang H; Tsui YM; Ho DW; Chung CY; Sze KM; Lee E; Cheung GC; Zhang VX; Wang X; Lyu X; Ng IO
    Hepatology; 2024 Feb; 79(2):323-340. PubMed ID: 37540188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells in gastric cancer: developments and clinical applications.
    Deng Q; Jiang B; Yan H; Wu J; Cao Z
    Clin Exp Med; 2023 Dec; 23(8):4385-4399. PubMed ID: 37548815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for elderly patients with early-stage hepatocellular carcinoma.
    Endo Y; Sasaki K; Moazzam Z; Lima HA; Alaimo L; Munir MM; Shaikh CF; Schenk A; Kitago M; Pawlik TM
    Br J Surg; 2023 Oct; 110(11):1527-1534. PubMed ID: 37548041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world setting.
    Falette-Puisieux M; Nault JC; Bouattour M; Lequoy M; Amaddeo G; Decaens T; Di Fiore F; Manfredi S; Merle P; Baron A; Locher C; Pellat A; Coriat R
    Ther Adv Med Oncol; 2023; 15():17588359231189425. PubMed ID: 37547443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors.
    Zhang L; Ma W; Qiu Z; Kuang T; Wang K; Hu B; Wang W
    Front Immunol; 2023; 14():1219929. PubMed ID: 37545502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Based on the Cancer Genome Atlas Database Development of a prognostic model of RNA binding protein in stomach adenocarcinoma.
    Abbas Raza SH; Zhong R; Xing S; Yu X; Chengcheng L; Zan L; Schreurs NM; Pant SD; Lei H
    Comput Biol Med; 2023 Sep; 164():107307. PubMed ID: 37544249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a "sandwich therapy" based on staged stereotactic radiosurgery and bevacizumab for large brainstem metastases.
    Wang Z; Chen H; Chen Q; Zhu Y; Bai Z; Li M; Zhang W
    Clin Neurol Neurosurg; 2023 Oct; 233():107911. PubMed ID: 37541158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S; Zhang L; Wang H
    Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.